medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2019, Number 3

<< Back Next >>

Acta Med 2019; 17 (3)

Vulvar cancer. Infrequent neoplasia with evolutionary treatment, recommendations for its diagnostic-therapeutic approach in initial stages

Gallegos HJF

Language: Spanish
References: 16
Page: 305-310
PDF size: 177.21 Kb.


Text Extraction

No abstract.


REFERENCES

  1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2016. CA Cancer J Clin. 2016; 66 (1): 7-30.

  2. SEER Cancer Statistics Factsheets: Vulvar Cancer. Bethesda, MD: National Cancer Institute. Available in: http://seer.cancer.gov/statfacts/html/vulva.html

  3. Gargano JW, Wilkinson EJ, Unger ER, Steinau M, Watson M, Huang Y et al. Prevalence of human papillomavirus types in invasive vulvar cancers and vulvar intraepithelial neoplasia 3 in the United States before vaccine introduction. J Low Genit Tract Dis. 2012; 16 (4): 471-479.

  4. Chase DM, Lin CC, Craig CD, Fedewa SA, Virgo KS, Farley JH et al. Disparities in vulvar cancer reported by the national cancer database: influence of sociodemographic factors. Obstet Gynecol. 2015; 126 (4): 792-802.

  5. Homesley HD, Bundy BN, Sedlis A, Yordan E, Berek JS, Jahshan A et al. Assessment of current International Federation of Gynecology and Obstetrics staging of vulvar carcinoma relative to prognostic factors for survival (a Gynecologic Oncology Group study). Am J Obstet Gynecol. 1991; 164 (4): 997-1003; discussion 1003-1004.

  6. Stroup AM, Harlan LC, Trimble EL. Demographic, clinical, and treatment trends among women diagnosed with vulvar cancer in the United States. Gynecol Oncol. 2008; 108 (3): 577-583.

  7. Koh WJ, Greer BE, Abu-Rustum NR, Campos SM, Cho KR, Chon HS et al. Vulvar cancer, Version 1.2017, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2017; 15 (1): 92-120.

  8. Gallegos-Hernández JF. El ganglio centinela. Concepto y aplicaciones prácticas en oncología. Rev Mex Anest. 2007; 30 (S1): 193-199.

  9. Reneé-Franklin C, Tanner EJ 3rd. Where are we going with sentinel lymph node mapping in gynecologic cancers? Curr Oncol Rep. 2018; 20 (12): 96.

  10. Oonk MH, van Hemel BM, Hollema H, de Hullu JA, Ansink AC, Vergote I et al. Size of sentinel-node metastasis and chances of non-sentinel-node involvement and survival in early stage vulvar cancer: results from GROINSS-V, a multicentre observational study. Lancet Oncol. 2010; 11 (7): 646-652.

  11. Pouwer AW, Arts HJ, van der Velden J, de Hullu JA. Limiting the morbidity of inguinofemoral lymphadenectomy in vulvar cancer patients; a review. Expert Rev Anticancer Ther. 2017; 17 (7): 615-624.

  12. Coleman RL, Ali S, Levenback CF, Gold MA, Fowler JM, Judson PL et al. Is bilateral lymphadenectomy for midline squamous carcinoma of the vulva always necessary? An analysis from Gynecologic Oncology Group (GOG) 173. Gynecol Oncol. 2013; 128 (2): 155-159.

  13. Oonk MHM, Planchamp F, Baldwin P, Bidzinski M, Brännström M, Landoni F et al. European Society of Gynaecological Oncology Guidelines for the management of patients with vulvar cancer. Int J Gynecol Cancer. 2017; 27 (4): 832-837.

  14. Sand FL, Nielsen DMB, Frederiksen MH, Rasmussen CL, Kjaer SK. The prognostic value of p16 and p53 expression for survival after vulvar cancer: A systematic review and meta-analysis. Gynecol Oncol. 2019; 152 (1): 208-217.

  15. Zhang J, Zhang Y, Zhang Z. Prevalence of human papillomavirus and its prognostic value in vulvar cancer: A systematic review and meta-analysis. PLoS One. 2018; 13 (9): e0204162.

  16. Ajmal Ghouri MS, Hassan A. Sentinel node mapping in vulvar carcinoma. J Pak Med Assoc. 2018; 68 (10): 1546.




2020     |     www.medigraphic.com